What You Need to Know About Aurora Cannabis Inc. (TSX:ACB) Stock

If you own or are thinking of investing in Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) stock, read this first!

| More on:
Knowledge concept with quote written on wooden blocks

Image source: Getty Images

Aurora Cannabis (TSX:ACB)(NYSE:ACB) stock is among the hottest stocks on the TSX right now, especially after it has climbed 88% from a low just a few months ago in December!

If you’re thinking of buying the growth stock, here are some important things you should know.

Aggressive growth

Aurora Cannabis is growing at a tremendous rate. It reported $1.4 million of revenue in 2016. Revenue has exploded 85 times to $119 million in about 3.5 years!

In the last reported quarter, fiscal Q2 2019, Aurora Cannabis saw net revenue growth of 83% compared to the previous quarter. This kind of crazy top-line growth is extraordinary in the midst of chatters about a global economic slowdown.


The company is aggressively growing by making strategic acquisitions and expanding internationally.

For example, last month, Aurora Cannabis expanded its footprint in Europe by entering Portugal. It bought a 51% ownership interest in a licence applicant, which allowed Aurora Cannabis to establish a local facility to produce medical cannabis and derivative products. Aurora Cannabis now has operations in 24 countries across five continents.

Further, early this month, Aurora Cannabis strengthened its position in Canada by completing the acquisition of Whistler Medical Marijuana Corporation.

Increasing costs

Aggressive growth naturally comes with increasing costs. While Aurora Cannabis increased revenue at a high pace, so has its costs. Specifically, the company’s selling, general, and administrative expense — a key metric showing cost not related to production — was more than 39 times what it was in 2016.

As a result of high operating expenses, Aurora Cannabis is unable to post consistent profits. The company was profitable in two of the last four reported quarters, which resulted in a trailing 12-month net loss of $71.6 million.

Balance sheet strength

Aurora Cannabis has a strong balance sheet. It last reported long-term debt of $339 million and a debt-to-asset ratio of less than 12%. However, the strong balance sheet came with the cost of diluting current shareholders.

The following graph shows that Aurora Cannabis has diluted shareholders more than its peers in the last three years.

ACB Average Diluted Shares Outstanding (Annual) Chart

ACB Average Diluted Shares Outstanding (Annual) data by YCharts.

Investor takeaway

The marijuana industry is highly competitive. So, none of the marijuana stocks mentioned are posting consistent profits yet. It’s very easy for investors to get hurt in their strikingly volatile stock price actions — especially so after ACB stock has run up.

If anything, speculative investors can look for a lower-risk entry point below $7 per share. If you already own the stock, consider exiting, perhaps, at about $12-14 per share.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Kay Ng has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »